Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to $29.3 million.

  • Medifast's Change in Acquisitions & Divestments rose 47499.02% to $29.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $82.1 million, marking a year-over-year increase of 19820.55%. This contributed to the annual value of $82.1 million for FY2025, which is 19820.55% up from last year.
  • Per Medifast's latest filing, its Change in Acquisitions & Divestments stood at $29.3 million for Q4 2025, which was up 47499.02% from $7.5 million recorded in Q3 2025.
  • Medifast's 5-year Change in Acquisitions & Divestments high stood at $30.8 million for Q2 2025, and its period low was $1.2 million during Q1 2022.
  • In the last 5 years, Medifast's Change in Acquisitions & Divestments had a median value of $6.3 million in 2024 and averaged $9.6 million.
  • Per our database at Business Quant, Medifast's Change in Acquisitions & Divestments crashed by 6653.23% in 2022 and then surged by 47499.02% in 2025.
  • Medifast's Change in Acquisitions & Divestments (Quarter) stood at $1.4 million in 2021, then skyrocketed by 182.25% to $4.0 million in 2022, then increased by 29.09% to $5.2 million in 2023, then fell by 1.81% to $5.1 million in 2024, then surged by 474.99% to $29.3 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $29.3 million for Q4 2025, versus $7.5 million for Q3 2025 and $30.8 million for Q2 2025.